191 related articles for article (PubMed ID: 25641432)
21. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
22. Trends in the risk of second primary cancer among bladder cancer survivors: a population-based cohort of 10 047 patients.
Muller J; Grosclaude P; Lapôtre-Ledoux B; Woronoff AS; Guizard AV; Bara S; Colonna M; Troussard X; Bouvier V; Trétarre B; Velten M; Jégu J
BJU Int; 2016 Jul; 118(1):53-9. PubMed ID: 26469096
[TBL] [Abstract][Full Text] [Related]
23. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.
Hisada M; Chen BE; Jaffe ES; Travis LB
J Natl Cancer Inst; 2007 Feb; 99(3):215-22. PubMed ID: 17284716
[TBL] [Abstract][Full Text] [Related]
24. Adolescent weight and height are predictors of specific non-Hodgkin lymphoma subtypes among a cohort of 2,352,988 individuals aged 16 to 19 years.
Leiba M; Leiba A; Keinan-Boker L; Avigdor A; Derazne E; Levine H; Kark JD
Cancer; 2016 Apr; 122(7):1068-77. PubMed ID: 26900677
[TBL] [Abstract][Full Text] [Related]
25. Risk of non-Hodgkin lymphoma after radiotherapy for solid cancers.
Kim CJ; Freedman DM; Curtis RE; Berrington de Gonzalez A; Morton LM
Leuk Lymphoma; 2013 Aug; 54(8):1691-7. PubMed ID: 23193978
[TBL] [Abstract][Full Text] [Related]
26. Exposure to environmental tobacco smoke and risk of non-Hodgkin lymphoma in nonsmoking men and women.
Diver WR; Teras LR; Gaudet MM; Gapstur SM
Am J Epidemiol; 2014 Apr; 179(8):987-95. PubMed ID: 24569639
[TBL] [Abstract][Full Text] [Related]
27. The relative risk of second primary cancers in Switzerland: a population-based retrospective cohort study.
Feller A; Matthes KL; Bordoni A; Bouchardy C; Bulliard JL; Herrmann C; Konzelmann I; Maspoli M; Mousavi M; Rohrmann S; Staehelin K; Arndt V;
BMC Cancer; 2020 Jan; 20(1):51. PubMed ID: 31964352
[TBL] [Abstract][Full Text] [Related]
28. Trends over three decades of the risk of second primary cancer among patients with head and neck cancer.
Jégu J; Binder-Foucard F; Borel C; Velten M
Oral Oncol; 2013 Jan; 49(1):9-14. PubMed ID: 22840787
[TBL] [Abstract][Full Text] [Related]
29. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
[TBL] [Abstract][Full Text] [Related]
30. Use of a case-mix approach to study the trends in the incidence of second primary cancers.
Gass B; Marrer E; Bara S; Ligier K; Molinié F; Colonna M; Daubisse-Marliac L; Trétarre B; Lapôtre-Ledoux B; Woronoff AS; Guizard AV; Bouvier V; Troussard X; Gaiddon C; Klein D; Velten M; Jégu J
Ann Epidemiol; 2018 May; 28(5):322-327. PubMed ID: 29550348
[TBL] [Abstract][Full Text] [Related]
31. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
[TBL] [Abstract][Full Text] [Related]
32. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
[TBL] [Abstract][Full Text] [Related]
33. Risk of second malignant neoplasms after cyclophosphamide-based chemotherapy with or without radiotherapy for non-Hodgkin lymphoma.
Xu Y; Wang H; Zhou S; Yu M; Wang X; Fu K; Qian Z; Zhang H; Qiu L; Liu X; Wang P
Leuk Lymphoma; 2013 Jul; 54(7):1396-404. PubMed ID: 23101661
[TBL] [Abstract][Full Text] [Related]
34. The association between histological subtype of a first primary endometrial cancer and second cancer risk.
Rhoades J; Vetter MH; Fisher JL; Cohn DE; Salani R; Felix AS
Int J Gynecol Cancer; 2019 Feb; 29(2):290-298. PubMed ID: 30718311
[TBL] [Abstract][Full Text] [Related]
35. Population-based incidence of lymphomas in the French Nord-Pas-de-Calais region between 2001 and 2005: Annual estimations and spatial analysis.
Detourmignies L; Leroyer A; Ligier K; Plouvier S; Genin M
Rev Epidemiol Sante Publique; 2019 Sep; 67(5):319-327. PubMed ID: 31327522
[TBL] [Abstract][Full Text] [Related]
36. Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy.
Pulte D; Gondos A; Brenner H
Leuk Lymphoma; 2009 Feb; 50(2):179-86. PubMed ID: 19197735
[TBL] [Abstract][Full Text] [Related]
37. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune diseases associated with non-Hodgkin lymphoma: a nationwide cohort study.
Fallah M; Liu X; Ji J; Försti A; Sundquist K; Hemminki K
Ann Oncol; 2014 Oct; 25(10):2025-2030. PubMed ID: 25081899
[TBL] [Abstract][Full Text] [Related]
39. Second Primary Malignancies in Mantle Cell Lymphoma: A US Population-based Study.
Shah BK; Khanal A
Anticancer Res; 2015 Jun; 35(6):3437-40. PubMed ID: 26026107
[TBL] [Abstract][Full Text] [Related]
40. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
